Personalized B-cell tailored dosing of ocrelizumab in patients with multiple sclerosis during the COVID-19 pandemic. van Lierop ZY, Toorop AA, van Ballegoij WJ, Olde Dubbelink TB, et al. Mult Scler 2021 Jul 9:13524585211028833. doi: 10.1177/13524585211028833.

Read + Share

Amedeo Smart

Independent Medical Education

van Lierop ZY, Toorop AA, van Ballegoij WJ, Olde Dubbelink TB, et al. Personalized B-cell tailored dosing of ocrelizumab in patients with multiple sclerosis during the COVID-19 pandemic. Mult Scler 2021 Jul 9:13524585211028833. doi: 10.1177/13524585211028833.
PMID: 34240631